<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>FERRIC SUBSULFATE- ferric subsulfateÂ solutionÂ </strong><br>CooperSurgical, Inc.<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>AstrinGyn</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_3644a871-ec6c-4953-a856-9fce81ecc3ca"></a><a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">AstrinGynÂ®</span></p>
<p><span class="Bold">(Ferric Subsulfate</span><span class="Bold">, </span><span class="Bold">Aqueous</span><span class="Bold">) </span></p>
<p><span class="Bold">REF 6065</span></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_7743406c-759b-40ab-ad70-95c01820443d"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">CONTENTS</span></h1>
<p class="First">Ferric subsulfate 259mg/g.  Preserved with benzalkonium chloride 0.005%.  Povidone USP 23.2%.  Glycerin USP 13.3%.  Purified Water USP.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_759c309f-40fe-42e1-b7c2-e156b71572b8"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">DESCRIPTION</span></h1>
<p class="First">AstrinGynÂ® (Ferric Subsulfate, Aqueous). </p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_c2c3bc54-9f9b-4f46-848c-5c1d3302a92a"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED</span></h1>
<p class="First">8 gm single-use glass bottles.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_93a887b1-b2be-467e-9db0-fffb393c8bb4"></a><a name="section-5"></a><p></p>
<h1><span class="Bold">ACTIONS &amp; USES</span></h1>
<p class="First">AstrinGynÂ® is a styptic agent used for achieving local hemostasis.  In punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.<span class="Bold"><span class="Sup">1</span></span>   One method for applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edges of the <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> and stretching the skin.  The <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wound</span> is then wiped with gauze, the ferric subsulfate solution applied, and the <span class="product-label-link" type="condition" conceptid="4200706" conceptname="Tension">tension</span> maintained for approximately 15 seconds.<span class="Bold"><span class="Sup">2</span></span>Â </p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_bf5f4dc7-6de7-4d63-b3b1-04538607913f"></a><a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<p class="First"><span class="Bold">For </span><span class="Bold">External Use Only</span>.  Should inadvertent ocular administration occur, the eye(s) should be washed immediately with large amounts of water or normal saline, occasionally lifting the upper and lower lids until no evidence of solution remains (approximately 15-20 minutes).</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_3844225c-221b-4cf8-a1f4-a794a17e8f18"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<p class="First">As with all iron solutions applied to dermal surfaces denuded of epithelium or to mucous membranes, topical application of AstrinGynÂ® (ferric subsulfate) may result in hyperpigmentation (â€œtattooingâ€?).<span class="Bold"><span class="Sup">3, 4</span></span></p>
<p>Microscopically, this hyperpigmentation may be observed as ferrugination of collagen fibers and fibrin.<span class="Bold"><span class="Sup">5</span></span>Â Â In one study of uterine cervical tissue, ferric subsulfate solution penetrated denuded mucosa and produced coagulation <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> to a maximum depth of 0.6Â mm.<span class="Bold"><span class="Sup">6</span></span><span class="Bold"></span>In an in vitro study, ferric subsulfate solution produced a radiopacity with a density intermediate between that of water/tissue and calcium.<span class="Bold"><span class="Sup">7</span></span>Should a re-biopsy of the same lesion be required, pathologists and other physicians involved in the care of the patient should be aware of the previous use of ferric subsulfate solution.  Previous use of ferric subsulfate solution may result in a histologic artifact upon re-biopsy of heavy <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">pigmentation</span>, similar to hemosiderin, together with shrinkage and discoloration of collagen bundles.<span class="Bold"><span class="Sup">8, 9</span></span> Similarly, previous use of ferric subsulfate solution may result in a radiographic artifact.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="LINK_6f0938d3-a860-4c0a-97df-3d4b3f482f52"></a><a name="section-8"></a><p></p>
<h1><span class="Bold">CAUTION</span></h1>
<p class="First">Federal law (USA) prohibits dispensing without a prescription.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="LINK_064d472f-052a-48ab-9b4a-58d111e1c41c"></a><a name="section-9"></a><p></p>
<h1><span class="Bold">STORAGE</span></h1>
<p class="First">Keep tightly closed and protect from light.Â Â <span class="Bold">DO NOT</span> use if seal isÂ broken. Â Store at room temperature 59Â°-86Â°F (15Â°-30Â° C).</p>
</div>
<div class="Section" data-sectionCode="69763-1">
<a name="LINK_9cfa1cd4-e4c0-4ef3-aee6-af88d6b0ac7c"></a><a name="section-10"></a><p></p>
<h1><span class="Bold">DISPOSAL</span></h1>
<p class="First">Opened containers with unused portions of product and applicator swabs containing residual product should be placed in a suitable, dry container for later disposal according to local hazardous waste practices.  Waste containing AstrinGynÂ® should not be subjected to any thermal process whether intended for destruction or recycling purposes.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="LINK_ed5fd482-c26c-453e-b5c1-334127ea4ec9"></a><a name="section-11"></a><p></p>
<h1><span class="Bold">REFERENCES</span></h1>
<ol class="Arabic">
<li>Armstrong RB, Nichols J. Pachance J. Punch biopsy <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span> treated with Monselâ€™s solution or a collagen matrix. A comparison of healing. Arch. Dermatol 1986;122:546-549.<br>
</li>
<li>Baden HP, Rapid hemostasis with Monselâ€™s solution (letter). Arch Dermatol 1984; 120:708.<br>
</li>
<li>Demis DJ, Clinical dermatology, Hagerstown MD: Harper &amp; Row, 1986; pp. 11-4:1-11-4:5.<br>
</li>
<li>Camisa C, Roberts W. Monsel solution tattooing (letter). J Am Acad Dermatol 1983;8:753-754.<br>
</li>
<li>Amazon K, Robinson MJ, Rywlin AM. Ferrugination caused by Monselâ€™s solution.  Clinical observations and experimentation. Am J Dermatopathol 1980;2:197-205.<br>
</li>
<li>Davis JR, Steinbronn KK, Graham AR, Dawson BV. Effects of Monselâ€™s solution in uterine cervix, AM J Clin PatholÂ 1984;82:332-335.<br>
</li>
<li>Horn MS, Circeo RB, Hassan C. Radiographic artifacts produced by silver nitrate and Monselâ€™s solution (letter). J Am Acad Dernatol 1983;8:560-562.<br>
</li>
<li>Olmstead PM, Lund HZ, Leonard DD. Monselâ€™s solution: a histologic nuisance. J Am Acad Dermatol 1980;3:492-498.<br>
</li>
<li>Wood C, Severin GL. Unusual histiocytic reaction to Monselâ€™s solution. Am J Dermatopathol 1980;2:261-264.</li>
</ol>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_96e54263-dea2-4a1b-b163-d26025cc3d0c"></a><a name="section-12"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<p class="First"><span class="Bold">AstrinGyn</span><span class="Bold"><span class="Sup"> Â®</span><br>Ferric Subsulfate, Aqueous<br>Contents<br>One Dozen (12) <br>8 gm Vials<br>NDC 59365-6065-1</span></p>
<p><span class="Bold"><img alt="AstrinGyn Â® Ferric Subsulfate, Aqueous Contents One Dozen (12) 8 gm Vials NDC 59365-6065-1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e93bce8b-de3b-4477-be41-d361e68849c6&amp;name=astringyn-1.jpg"></span></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_dd63ad5a-d3ff-4144-a7b5-295d70cf18e1"></a><a name="section-13"></a><p></p>
<h1><span class="Bold">PRINCIPAL DISPLAY PANEL</span></h1>
<p class="First"><span class="Bold">8gm</span><span class="Bold"> Â Â Â Â Â  NDC 59365-6065-0</span><span class="Bold"><br>AstrinGyn</span><span class="Bold"><span class="Sup"> Â®</span></span><span class="Bold"><br>(Ferric Subsulfate)</span><span class="Bold"><br>Aqueous</span></p>
<div class="Figure"><img alt="8gm NDC 59365-6065-0 AstrinGyn Â® (Ferric Subsulfate) Aqueous" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=e93bce8b-de3b-4477-be41-d361e68849c6&amp;name=astringyn-2.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>FERRIC SUBSULFATEÂ 		
					</strong><br><span class="contentTableReg">ferric subsulfate solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:59365-6065</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>FERRIC SUBSULFATE</strong> (FERRIC CATION) </td>
<td class="formItem">FERRIC CATION</td>
<td class="formItem">259Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POVIDONES</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59365-6065-1</td>
<td class="formItem">12  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:59365-6065-0</td>
<td class="formItem">8 g in 1 VIAL, SINGLE-USE; Combination Product Type = C112160</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">10/01/1992</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>CooperSurgical, Inc.
							(801895244)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 11/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>9eb6dd79-ecfd-45c8-91b5-47bd70249f2d</div>
<div>Set id: e93bce8b-de3b-4477-be41-d361e68849c6</div>
<div>Version: 9</div>
<div>Effective Time: 20141117</div>
</div>
</div>Â <div class="DistributorName">CooperSurgical, Inc.</div></p>
</body></html>
